Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Tetra Discovery receives phase II SBIR grant to develop new depression drug

Sep. 27, 2013

Amgen patents Na(v)1.7 sodium channel blockers

Sep. 26, 2013

NuPathe doses adolescent patients in phase I Zecuity trial

Sep. 26, 2013

Neurovance begins phase II study of EB-1020 SR in adults with ADHD

Sep. 26, 2013

Lpath receives NIH grant for Lpathomab

Sep. 26, 2013

Boehringer Ingelheim and Vitae Pharmaceuticals patent BACE1 inhibitors

Sep. 25, 2013

FDA issues complete response letter for sugammadex

Sep. 25, 2013

BioMarin begins dosing in phase I/II trial of enzyme replacement therapy for Batten disease

Sep. 25, 2013

NIH funding boosts new Alzheimer's disease research

Sep. 25, 2013

First patient treated with NTCell regenerative cell therapy for Parkinson's disease

Sep. 25, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...